Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-06-29

FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Prochlorperazine from Cosette Pharmaceuticals, Inc., typically used to prevent nausea and vomiting, indicating chang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Compazine (Prochlorperazine)

Snippet

SUPPL AP for PROCHLORPERAZINE (PROCHLORPERAZINE)